COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

被引：4
|
作者：
Declercq, Jozefien [1 ,2 ,3 ]
Tobback, Els [4 ]
Vanhee, Stijn [2 ,3 ]
De Ruyck, Natalie [1 ]
Gerlo, Sarah [5 ,6 ]
Gevaert, Philippe [1 ]
Vandekerckhove, Linos [3 ,4 ,5 ]
机构：
[1] Univ Ghent, Upper Airways Res Lab URL, Dept Otorhinolaryngol, C Heymanslaan 10,1P1, Ghent, Belgium
[2] VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium
[3] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium
[4] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium
[5] Univ Ghent, Dept Internal Med & Pediat, HIV Cure Res Ctr, Ghent, Belgium
[6] Univ Ghent, Dept Biomol Med, Ghent, Belgium
来源：
ALLERGY | 2022年 / 77卷 / 01期
关键词：
D O I：
10.1111/all.15101
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：304 / 307
页数：4
相关论文
共 50 条
  • [21] Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)
    Tran, A. P.
    Tassone, D.
    Nossent, J. C.
    Ding, N. S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I403 - I404
  • [22] Effectiveness of BNT162b2 and ChAdOx1 Vaccines against Symptomatic COVID-19 among Healthcare Workers in Kuwait: A Retrospective Cohort Study
    Alali, Walid Q.
    Ali, Lamiaa A.
    AlSeaidan, Mohammad
    Al-Rashidi, Mohammad
    HEALTHCARE, 2021, 9 (12)
  • [23] Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)
    Tran, A. P.
    Tassone, D.
    Nossent, J. C.
    Ding, N. S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I403 - I404
  • [24] Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
    Reiter, Rieke
    Von Blanckenburg, Pia
    Mutters, Reinier
    Thiemer, Julia
    Gessner, Reinhard
    Seifart, Ulf
    VACCINES, 2022, 10 (05)
  • [25] Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
    Eduardo Hermosilla
    Ermengol Coma
    Junqing Xie
    Shuo Feng
    Carmen Cabezas
    Leonardo Méndez-Boo
    Francesc Fina
    Elisabet Ballo
    Montserrat Martínez
    Manuel Medina-Peralta
    Josep Maria Argimon
    Daniel Prieto-Alhambra
    Nature Communications, 13
  • [26] Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
    Hermosilla, Eduardo
    Coma, Ermengol
    Xie, Junqing
    Feng, Shuo
    Cabezas, Carmen
    Mendez-Boo, Leonardo
    Fina, Francesc
    Ballo, Elisabet
    Martinez, Montserrat
    Medina-Peralta, Manuel
    Argimon, Josep Maria
    Prieto-Alhambra, Daniel
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [27] Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
    Lim, So Yun
    Kim, Ji Yeun
    Park, Soonju
    Kwon, Ji-Soo
    Park, Ji Young
    Cha, Hye Hee
    Suh, Mi Hyun
    Lee, Hyun Jung
    Lim, Joon Seo
    Bae, Seongman
    Jung, Jiwon
    Lee, Nakyung
    Kim, Kideok
    Shum, David
    Jee, Youngmee
    Kim, Sung-Han
    IMMUNE NETWORK, 2021, 21 (06)
  • [28] Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection
    Alfaleh, Amjad
    Alkattan, Abdullah
    Alzaher, Abrar
    Radwan, Nashwa
    Mahmoud, Nagla
    Alageel, Alaa
    Alhabib, Dina
    Alsalameen, Eman
    Sagor, Khlood
    Haji, Alhan
    Alfaifi, Amal
    Alabdulkareem, Khaled
    Ibrahim, Mona
    CLINICAL DRUG INVESTIGATION, 2022, 42 (10) : 799 - 806
  • [29] Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection
    Amjad Alfaleh
    Abdullah Alkattan
    Abrar Alzaher
    Nashwa Radwan
    Nagla Mahmoud
    Alaa Alageel
    Dina Alhabib
    Eman Alsalameen
    Khlood Sagor
    Alhan Haji
    Amal Alfaifi
    Khaled Alabdulkareem
    Mona Ibrahim
    Clinical Drug Investigation, 2022, 42 : 799 - 806
  • [30] Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY
    Hulme, William J.
    Williamson, Elizabeth J.
    Green, Amelia C. A.
    Bhaskaran, Krishnan
    McDonald, Helen, I
    Rentsch, Christopher T.
    Schultze, Anna
    Tazare, John
    Curtis, Helen J.
    Walker, Alex J.
    Tomlinson, Laurie A.
    Palmer, Tom
    Horne, Elsie M. F.
    MacKenna, Brian
    Morton, Caroline E.
    Mehrkar, Amir
    Morley, Jessica
    Fisher, Louis
    Bacon, Sebastian C. J.
    Evans, David
    Inglesby, Peter
    Hickman, George
    Davy, Simon
    Ward, Tom
    Croker, Richard
    Eggo, Rosalind M.
    Wong, Angel Y. S.
    Mathur, Rohini
    Wing, Kevin
    Forbes, Harriet
    Grint, Daniel J.
    Douglas, Ian J.
    Evans, Stephen J. W.
    Smeeth, Liam
    Bates, Chris
    Cockburn, Jonathan
    Parry, John
    Hester, Frank
    Harper, Sam
    Sterne, Jonathan A. C.
    Hernan, Miguel A.
    Goldacre, Ben
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 378
12345